← All trials
NCT05181735
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 18, 2022
- Primary completion
- May 19, 2027
- Completion date
- Nov 19, 2027
- First posted
- Jan 6, 2022
- Last posted
- May 20, 2022
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Groupe Francophone des MyelodysplasiesLead sponsor
- CelgeneCollaborator
- Hôpital Saint LouisOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.